Mesfin TegenuCEO at RxPardigmSpeaker
Agenda Sessions
Resolving the 340B "Double Payment" Issue Using a Neutral Clearinghouse to Address Stakeholder Concerns Amidst Policy Shifts- The emerging of a 340B claims clean drug rebate contracting strategy
, 2:15pmView Session